logo
Select company
Select metric
4.98Current Ratio
VS
Market
83
Sector
64
Industry
51
History
50
$ 35.94Close
$ 10.84 - $ 35.94 52-Week Range
Ticker Information

Ticker

INBX

Company Name

INHIBRX BIOSCIENCES INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

INHIBRX BIOSCIENCES INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

INBX - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 193.96M4.98$ 38.94M
3/31/2025$ 223.39M5.12$ 43.64M
12/31/2024$ 160.4M3.94$ 40.73M
9/30/2024$ 207.45M4.7$ 44.09M
6/30/2024$ 242.06M6.2$ 39.05M
3/31/2024$ 274.54M3.82$ 71.87M
12/31/2023$ 295.36M5.25$ 56.31M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • INHIBRX BIOSCIENCES INC's latest trailing twelve months (TTM) Current Ratio stands at 5.25.
  • Over the past 5 years, INHIBRX BIOSCIENCES INC's average Current Ratio has been 4.86.
  • The median Current Ratio for INHIBRX BIOSCIENCES INC during this period was 4.98
  • INHIBRX BIOSCIENCES INC reached its highest Current Ratio over the past 5 years at 6.2.
  • The lowest Current Ratio recorded by INHIBRX BIOSCIENCES INC in the same timeframe 3.82

INHIBRX BIOSCIENCES INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
NWBO : NORTHWEST BIOTHERAPEUTICS INC 0.07RNAC : CARTESIAN THERAPEUTICS INC 13.33VSTM : VERASTEM INC 3.46HUMA : HUMACYTE INC 2.45OTLK : OUTLOOK THERAPEUTICS INC 0.67ABEO : ABEONA THERAPEUTICS INC 6.73MREO : MEREO BIOPHARMA GROUP PLC 8.13CATX : PERSPECTIVE THERAPEUTICS INC 15.09PLUR : PLURI INC 0.68DTIL : PRECISION BIOSCIENCES INC 5.18

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for INHIBRX BIOSCIENCES INC is calculated as follows: AssetsC [ $ 295.36M ] / LiabilitesC [ $ 56.31M ]
(=) Current Ratio [ 5.25 ]

INBX - Current Ratio, Last 5 years

3.82

Minimum

Mar 31, 2024

6.2

Maximum

Jun 30, 2024

4.86

Average

4.98

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44